1983 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giuseppe Sanguineti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 96 Similar Profiles
Radiotherapy Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
radiation therapy Physics & Astronomy
Intensity-Modulated Radiotherapy Medicine & Life Sciences
cancer Physics & Astronomy
Therapeutics Medicine & Life Sciences
Neck Medicine & Life Sciences
Oropharyngeal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2019

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D’Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 others, Fabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Feb 1 2019, In : Cancer Biology and Therapy. 20, 2, p. 192-200 9 p.

Research output: Contribution to journalArticle

Taxoids
Observational Studies
Retrospective Studies
Breast Neoplasms
Maintenance

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

Pizzuti, L., Krasniqi, E., Barchiesi, G., Della Giulia, M., Izzo, F., Sanguineti, G., Marchetti, P., Mazzotta, M., Giusti, R., Botticelli, A., Gamucci, T., Natoli, C., Grassadonia, A., Tinari, N., Iezzi, L., Tomao, S., Tomao, F., Tonini, G., Santini, D., Astone, A. & 30 others, Michelotti, A., De Angelis, C., Mentuccia, L., Vaccaro, A., Magnolfi, E., Gelibter, A., Magri, V., Cortesi, E., D'Onofrio, L., Cassano, A., Rossi, E., Cazzaniga, M., Moscetti, L., Omarini, C., Piacentini, F., Fabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Bria, E., La Verde, N., Garufi, C., Paris, I., Giotta, F., Lorusso, V., De Maria, R., Ciliberto, G., Sperduti, I., Barba, M. & Vici, P., Jan 1 2019, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

Open Access
Immunohistochemistry
Breast Neoplasms
Neoplasms
Estrogen Receptors
Disease-Free Survival

Eribulin in triple negative metastatic breast cancer: Critic interpretation of current evidence and projection for future scenarios

Pizzuti, L., Krasniqi, E., Barchiesi, G., Mazzotta, M., Barba, M., Amodio, A., Massimiani, G., Pelle, F., Kayal, R., Vizza, E., Grassadonia, A., Tomao, S., Venuti, A., Gamucci, T., Marchetti, P., Natoli, C., Sanguineti, G., Ciliberto, G. & Vici, P., Jan 1 2019, In : Journal of Cancer. 10, 24, p. 5903-5914 12 p.

Research output: Contribution to journalReview article

Open Access
eribulin
Triple Negative Breast Neoplasms
Therapeutics
Drug Therapy
Taxoids

Immunotherapy in HER2-positive breast cancer: State of the art and future perspectives

Krasniqi, E., Barchiesi, G., Pizzuti, L., Mazzotta, M., Venuti, A., Maugeri-Saccà, M., Sanguineti, G., Massimiani, G., Sergi, D., Carpano, S., Marchetti, P., Tomao, S., Gamucci, T., De Maria, R., Tomao, F., Natoli, C., Tinari, N., Ciliberto, G., Barba, M. & Vici, P., Oct 29 2019, In : Journal of Hematology and Oncology. 12, 1, 111.

Research output: Contribution to journalReview article

Open Access
Immunotherapy
Breast Neoplasms
Immune System
Tumor-Infiltrating Lymphocytes
Active Immunotherapy